文献速递功能神经外科

帕金森病丘脑底核刺激位点与临床改善:一种主动触点定位新方法

Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
PubMed 文献 · J Neurosurg · 2016-02-05

研究纳入40例双侧丘脑底核脑深部电刺激的帕金森病患者,基于Morel图谱构建考虑解剖变异的3D图谱,用术前术后MRI体积法定位电极与主动触点。6个月时UPDRS-III评分降低58.0%±16.5%、左旋多巴等效日剂量降低64.9%±21.0%(均p<0.001);触点位于中线外侧约12 mm时降幅最大。

要点

  • 丘脑底核刺激6个月使UPDRS-III评分降低58.0%±16.5%、左旋多巴等效日剂量降低64.9%±21.0%(均p<0.001)。
  • 主动触点位于中线外侧约12 mm时总UPDRS-III、对侧UPDRS-III及左旋多巴等效日剂量降幅最大(分别为64%、76%、73%)。
  • 触点位于中线外侧约10 mm时总UPDRS-III、对侧UPDRS-III及左旋多巴等效日剂量仅降低47%、41%、33%。

核心结论

  • 作者报告了一种评估慢性丘脑底核刺激电极与触点位置的精确新方法;主动触点位于丘脑底核运动区嘴侧和最外侧部分及该区与未定带、丘脑束交界处时抗帕金森病获益最大。

研究设计与样本

  • 研究纳入40例双侧丘脑底核脑深部电刺激的帕金森病患者,基于Morel图谱构建考虑个体解剖变异并将丘脑底核划分为功能区的3D图谱,用术前术后MRI对伪影行体积评估定位电极与主动触点,并以基于椭球表示的新体积法在3D图谱中定位触点,采用层次聚类法对触点位置与相应临床改善行同质分组分类。

主要发现

  • 丘脑底核刺激使UPDRS-III评分降低58.0%±16.5%(p<0.001)、左旋多巴等效日剂量降低64.9%±21.0%(p<0.001)。
  • 主动触点位于中线外侧约12 mm时总UPDRS-III评分降低64%、对侧UPDRS-III评分降低76%、左旋多巴等效日剂量降低73%,前后轴与背腹轴位置未见影响。
  • 主动触点位于中线外侧约10 mm时总UPDRS-III评分降低47%、对侧UPDRS-III评分降低41%、左旋多巴等效日剂量降低33%。
  • 按椭球法定位,获益最高的主动触点位于丘脑底核嘴侧和最外侧部分及该区与未定带、丘脑束的交界处;位于运动性丘脑底核区最内侧的触点临床疗效最低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is widely used in patients with Parkinson's disease (PD). However, which target area of this region results in the highest antiparkinsonian efficacy is still a matter of debate. The aim of this study was to develop a more accurate methodology to locate the electrodes and the contacts used for chronic stimulation (active contacts) in the subthalamic region, and to determine the position at which stimulation conveys the greatest clinical benefit. METHODS The study group comprised 40 patients with PD in whom bilateral DBS electrodes had been implanted in the STN. Based on the Morel atlas, the authors created an adaptable 3D atlas that takes into account individual anatomical variability and divides the STN into functional territories. The locations of the electrodes and active contacts were obtained from an accurate volumetric assessment of the artifact using preoperative and postoperative MR images. Active contacts were positioned in the 3D atlas using stereotactic coordinates and a new volumetric method based on an ellipsoid representation created from all voxels that belong to a set of contacts. The antiparkinsonian benefit of the stimulation was evaluated by the reduction in the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) score and in the levodopa equivalent daily dose (LEDD) at 6 months. A homogeneous group classification for contact position and the respective clinical improvement was applied using a hierarchical clustering method. RESULTS Subthalamic stimulation induced a significant reduction of 58.0% ± 16.5% in the UPDRS-III score (p < 0.001) and 64.9% ± 21.0% in the LEDD (p < 0.001). The greatest reductions in the total and contralateral UPDRS-III scores (64% and 76%, respectively) and in the LEDD (73%) were obtained when the active contacts were placed approximately 12 mm lateral to the midline, with no influence of the position being observed in the anteroposterior and dorsoventral axes. In contrast, contacts located about 10 mm from the midline only reduced the global and contralateral UPDRS-III scores by 47% and 41%, respectively, and the LEDD by 33%. Using the ellipsoid method of location, active contacts with the highest benefit were positioned in the rostral and most lateral portion of the STN and at the interface between this subthalamic region, the zona incerta, and the thalamic fasciculus. Contacts placed in the most medial regions of the motor STN area provided the lowest clinical efficacy. CONCLUSIONS The authors report an accurate new methodology to assess the position of electrodes and contacts used for chronic subthalamic stimulation. Using this approach, the highest antiparkinsonian benefit is achieved when active contacts are located within the rostral and the most lateral parts of the motor region of the STN and at the interface of this region and adjacent areas (zona incerta and thalamic fasciculus).

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Garcia-Garcia D, Guridi J, Toledo JB, et al. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization. J Neurosurg. 2016. PMID: 26848922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。